cis-Diamminedichloroplatinum(II), Pt 64.5% min., Alfa Aesar™

Potent Anticancer Agent That Blocks DNA Synthesis.

Manufacturer: Alfa Aesar 10471-01

Quantity 0.25g

 View more versions of this product

Catalog No. AA1047101

  Check Availability
Add to Cart

    Chemical Identifiers

    CAS 15663-27-1
    Physical Form Microcrystalline
    Molecular Formula Cl2H6N2Pt
    Formula Weight 300.06g/mol
    MDL Number MFCD00011623
    Synonym Cisplatin
    Chemical Name or Material cis-Diamminedichloroplatinum(II), Potent anticancer agent that blocks DNA synthesis

    Specifications

    Appearance Yellow micro crystals
    Odor Odorless
    Color Yellow
    Quantity 0.25g
    CAS 15663-27-1
    Physical Form Microcrystalline
    Molecular Formula Cl2H6N2Pt
    Formula Weight 300.06g/mol
    MDL Number MFCD00011623
    Synonym Cisplatin
    Health Hazard 1 H300-H315-H319-H317-H335-H334-H350: Fatal if swallowed. Causes skin irritation. Causes serious eye irritation. May cause an allergic skin reaction. May cause respiratory irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause cancer.
    DOT Information DOT Class: 6.1, Packing Group: II
    EINECS Number 239-733-8
    Chemical Name or Material cis-Diamminedichloroplatinum(II), Potent anticancer agent that blocks DNA synthesis

    H300-H315-H319-H317-H335-H334-H350: Fatal if swallowed. Causes skin irritation. Causes serious eye irritation. May cause an allergic skin reaction. May cause respiratory irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause cancer.

    SDS & Safety Documents

  • Description & Specifications
  • Safety and Handling

Related Products


Product Content Feedback

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit